Accu-Chek® Insight insulin pump system, manufactured by Roche Diabetes Care – risk of inappropriate treatment
- Medicines and Healthcare products Regulatory Agency
- 12 May 2016
- 12 May 2016
- Alert type:
- Medical device alert
- Medical specialism:
- General practice
Risk of a hypoglycaemic event if users misinterpret maintenance message ‘M-83 pump not able to complete task’. Users are advised to check pump history before re-initiating a programmed task (e.g. bolus delivery) MDA/2016/005.
- Identify users of the Accu-Chek® Insight insulin pump system.
- Ensure that all patients and users receive the manufacturer’s Field Safety Notice FSN and that they understand the problem and the advice given by the manufacturer.
- Include a copy of the FSN with the Accu-Chek® Insight insulin pump system user manual. The manufacturer will update the manual soon.
- Return FSN acknowledgment form to Roche.
All healthcare workers, carers and patients who use these devices. Deadlines for actions.
Deadlines for actions
Actions underway: 02 June 2016
Actions complete: 27 June 2016
Problem / background
The system includes the insulin pump and the diabetes manager. When the diabetes manager displays maintenance message ‘M83 Pump not able to complete task’ there is a risk that users may repeat the programmed task. For example, if the task is to deliver a bolus, and this message is displayed, users may request the task to be repeated, resulting in two bolus doses. Users are instructed to check the pump’s history as this will indicate whether the programmed task has been completed. Roche issued an FSN in March 2016 but has not received enough acknowledgments to confirm that healthcare professionals and users have received and acted on the instructions.
Roche Diabetes Care Accu-Chek Pump Care Line
Telephone: 0800 731 22 91
If you are responsible for cascading these alerts in your organisation, these are our suggested distribution lists.
Trusts (NHS boards in Scotland)
CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:
- Community diabetes specialist nurses
- Community hospitals
- Diabetes clinics/outpatients
- Diabetes nurse specialists
- Diabetes, directors of
- EBME departments
- Equipment stores
- Outpatient clinics
- Paediatric diabetes nurse specialists
- Risk managers
- Supplies managers
NHS England area teams
CAS liaison officers for onward distribution to all relevant staff including:
- Community pharmacists
- General practitioners
Establishments registered with the Care Quality Commission (CQC) (England only)
- Hospitals in the independent sector
- Independent treatment centres
- Private medical practitioners
Send enquiries about this notice to MHRA, quoting reference number MDA/2016/005 or 2016/003/003/701/016.
Jillan Hussein or Jenifer Hannon, MHRA
Tel: 020 3080 7148 / 7153
Mark Grumbridge, MHRA
Tel: 020 3080 7128 Email: firstname.lastname@example.org
Reporting adverse incidents in England
Alerts in Northern Ireland are distributed via the NI SABS system.
Enquiries and adverse incident reports in Northern Ireland should be addressed to:
Northern Ireland Adverse Incident Centre, CMO Group,
Department of Health, Social Services and Public Safety
Tel: 028 9052 3868
Fax: 028 9052 3900
Please report directly to NIAIC using the forms on our website.
Enquiries and adverse incident reports in Scotland should be addressed to:
Incident Reporting and Investigation Centre,
Health Facilities Scotland,
NHS National Services Scotland
Tel: 0131 275 7575
Fax: 0131 314 0722
Reporting adverse incidents in Scotland
NHS Boards and Local Authorities in Scotland – report to Health Facilities Scotland.
Contractors such as private hospitals carrying out NHS work and private care homes that accept social work funded clients – report to Health Facilities Scotland.
Enquiries in Wales should be addressed to:
Healthcare Quality Division,
Tel: 02920 823 624 / 02920 825 510
Reporting adverse incidents in Wales
Published: 12 May 2016
Issued: 12 May 2016
Alert type: Medical device alert
Medical specialism: General practice